FOURTH ALLONGE AND AMENDMENT to SERIES A WARRANTS OF ELXSI CORPORATION --------------------------------------Series a Warrant Amendment • April 15th, 2003 • Elxsi Corp /De// • Retail-eating places
AMENDMENT TO SERIES A WARRANT TO PURCHASE SHARES OF COMMON STOCK OF BPO MANAGEMENT SERVICES, INC.Series a Warrant Amendment • April 28th, 2008 • BPO Management Services • Services-prepackaged software
This Amendment to Series A Warrant to Purchase Shares of Common Stock of BPO Management Services, Inc. (this “Amendment”) is effective as of April 18, 2008, by BPO Management Services, Inc., a Delaware corporation (“Issuer”), in favor of ________________ (“Holder”). Issuer and Holder are, together, the “Parties.”
SERIES A WARRANT AMENDMENTSeries a Warrant Amendment • February 3rd, 2016 • Cesca Therapeutics Inc. • Laboratory apparatus & furniture • New York
This Series A Warrant Amendment (this “Amendment”) is entered into as of [●], 2016 (the “Effective Date”) by and between Cesca Therapeutics Inc., a Delaware corporation (the “Company”), and [Sabby Healthcare Master Fund, Ltd. / Sabby Volatility Warrant Master Fund, Ltd.] (“Sabby”). The Company and Sabby are referred to herein, collectively, as the “Parties”.
AMENDMENT NO. 1 TO THE SERIES A WARRANT TO PURCHASE COMMON STOCKSeries a Warrant Amendment • September 13th, 2021 • Sierra Oncology, Inc. • Pharmaceutical preparations • New York
This Amendment No. 1 to the Series A Warrant to Purchase Common Stock dated September 8, 2021 is made effective as of September 8, 2021 (the “Amendment”), by and among Sierra Oncology, Inc., a Delaware corporation (the “Company”), and [ ] (the “Investor” and together with the Company, the “Parties”).
AMENDMENT TO SERIES A WARRANT TO SUBSCRIBE FOR ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARESSeries a Warrant Amendment • May 24th, 2024 • Evaxion Biotech a/S • Biological products, (no disgnostic substances)
THIS AMENDMENT TO SERIES A WARRANT TO SUBSCRIBE FOR ORDINARY SHARES REPRESENTED BY AMERICAN DEPOSITARY SHARES (this “Amendment”), dated as of May __, 2024, is entered into by and between Evaxion Biotech A/S, a public limited liability company incorporated under the laws of the Kingdom of Denmark (the “Company”), and ______________ (the “Holder”). Capitalized terms used but not otherwise defined herein shall have the meaning ascribed to them in the Warrant (as defined herein).
AMENDMENT NO. 1 TO SERIES A WARRANT TO PURCHASE SHARES OF COMMON STOCK OF GLOWPOINT, INC.Series a Warrant Amendment • September 24th, 2007 • Glowpoint Inc • Telephone communications (no radiotelephone) • New York
THIS AMENDMENT NO. 1 TO SERIES A WARRANT TO PURCHASE SHARES OF COMMON STOCK OF GLOWPOINT, INC. (this “Amendment”), dated as of September 21, 2007, is made by and among Glowpoint, Inc., a Delaware corporation (the “Issuer”) and ___________________ (the “Holder”).
